Health
Immunity developed by SARS-CoV-2 infection can protect against E484K variants, suggests study – News-Medical.Net
A team of scientists from Japan has recently investigated the neutralizing potency of convalescent sera against currently circulating SARS-CoV-2 variants with multiple…
A team of scientists from Japan has recently investigated the neutralizing potency of convalescent sera against currently circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with multiple spike mutations.
The study’s findings reveal that the variants containing Y543F or N501Y spike mutations are capable of evading neutralization by SARS-CoV-2-induced antibodies. However, no such immune evading potency has been observed for the variants with only the E484K spike mutation.
…
-
Noosa News22 hours agoLaidley e-scooter death: Tragic new details after Summah Richards killed in freak accident
-
General23 hours agoMinjee Lee rallies after third-round meltdown to share fifth place at LA Championship
-
General16 hours agoUkraine says Russia has ramped up attacks despite ‘Easter truce’
-
General15 hours agoPope Francis appears Easter Sunday to deliver blessing as recovery continues